Connect with us

breaking news

Who’d Have Guessed It!!! Germany’s cannabis plans “scaled back”

Published

on


I really should get down to the bookies to see if they’ll take wagers on this.

Everytime a new jurisdiction promises the world on cannabis and then roll it back to a format that just encourages the un-regulated market even further.

Business of Cannabis has the lowdown on Germany’s failure to get the whole shebang across the line with the excuse that the problem lies with the EU.

Yesterday Germany’s Social Democratic Party (SPD) said it no longer expected a fully legalised cannabis market to be rolled out in the near future.

According to German political news publication Der Speigel, the SPD, part of the country’s ruling ‘traffic light’ coalition, has said it believes ‘comprehensive legalisation is obviously not feasible in the short term for reasons of European law’.

The news comes just weeks after the Health Minister Karl Lauterbach made headlines by stating his feedback from the EU was ‘very good’, and he expected to publish his draft law in a few weeks.

While this will come as a blow for many businesses and investors positioning themselves to capitalise on the promise of an adult-use market, others operating within its medical cannabis space are breathing a sigh of relief, after threats of major reform ultimately came to nothing.

Changes to medical cannabis framework

Earlier this month, Business of Cannabis reported that the G-BA was set to announce major changes to the country’s medical cannabis framework, potentially making it far more difficult for patients to have their prescriptions reimbursed.

Under the proposals put forward in October 2022, the G-BA would have made medical cannabis the very last option for patients, who would have needed to prove that they have tried and failed to be treated with alternative medicines, while extracts would have been heavily favoured, with the prescription of cannabis flowers needing to be specially justified.

More crucially, general practitioners without additional qualifications would have been able to prescribe medical cannabis in exceptional cases only, further reducing access.

However, in the hearing held on Thursday, March 16, the G-BA rolled back on almost all its heavily criticised proposals, in what has been described as a ‘win’ for patients, doctors and the industry at large.

The Co-founder and Managing Director of German medical cannabis pharmaceutical wholesaler AlephSana, Boris Moshkovits, explained: “In essence, the new regulation is following more or less the framework of the initial regulation.”

After ‘intense discussions’ at the hearing, the two ‘critical points’ on GPs’ right to prescribe and questions regarding the mode of delivery remained unchanged, other than ‘one sentence added in the regulation’.

According to Mr Moshkovits, this could lead to ‘more complicated access’ to medical cannabis, as prescribers are now required to check if finished products like Sativex, Canames or Epidyolex could be prescribed instead of dried flower or extract.

“This is a crucial point for patients with reimbursement, as they (or more so the prescriber) must argue that dried flower or extract can help them better. For patients paying out of pocket, nothing should really change.

“Another rather positive development is that patients in a critical condition, after surgery and in palliative care have to hear back on the cost reimbursement within three days and can only be refused for important reasons. That will probably mean easier access for these patients.”

Cannovum’s CEO Pia Marten told Business of Cannabis: “I think I can speak for myself, Cannovum and probably for the entire medical cannabis industry when I say that we’re very pleased with the outcome of the directive.

“We’re pleased that they actually heard all those doctors and patient advocates, and made sure that access to cannabis-based medicines is still there… another key takeaway for me was that the G-BA directive really emphasises patient safety.

“I think there’s also a need to make sure that patients are cared for in light of upcoming legalisation. I think it’s an important sign that medical cannabis is here to stay in Germany, and they do not disregard it just as a recreational drug. I think this will also highly impact what is going to happen in the recreational market.”

Read more at 

https://businessofcannabis.com/cannabis-as-a-medicine-is-here-to-stay-in-germany-but-businesses-are-still-waiting-for-clarification-on-recreational-legalisation/?mc_cid=65ec023e71

 

 



Source link

Continue Reading

breaking news

South Africa: Stop arresting cannabis users, Human Rights Commission urges police after complaints about arrests from Rastafarian community.

Published

on

By


The SA Human Rights Commission (SAHRC) has written to national police commissioner Gen Fannie Masemola to express concern over the ongoing arrests of cannabis users and Rastafarians despite a law permitting the private cultivation and use of cannabis by adults.

The private use, possession and cultivation of cannabis by adults was decriminalised in 2018, with President Cyril Ramaphosa signing the Cannabis for Private Purposes Act on May 28 this year.

However, the SAHRC has received complaints about arrests from cannabis users and the Rastafarian community.

“As the festive season approaches, the SAHRC reminds law enforcement, in particular the SA Police Service and the National Prosecuting Authority, that the arrest and/or prosecution of adults for the private use, possession or cultivation of cannabis, as well as making assumptions about dealing, is inconsistent with the law and national operational directives. Such arrests and/or prosecutions could lead to human rights violations being perpetrated by law enforcement,” the SAHRC said.

Since August last year, a directive issued by Masemola titled “Arrests by the SA Police Service for Cannabis — Related Matters” recognised legislation did not prescribe the quantity of the cannabis in possession of or cultivated by an adult to presume it was the unlawful dealing of cannabis.

“Therefore, as things stand, the directive directs that adults may not be arrested on the presumption of dealing in cannabis,” the SAHRC said.

The SAHRC urged the department of justice and constitutional development to consult with the Rastafari and other cannabis-using communities to draft regulations for the Cannabis for Private Purposes Act. This includes advice on a specific commencement date for the act, which has yet to come into effect.

https://www.timeslive.co.za/news/south-africa/2024-12-24-stop-arresting-cannabis-users-sa-human-rights-commission-urges-police/



Source link

Continue Reading

breaking news

Press Release: Health Canada releases new data on cannabis use in Canada – “18% of people who had used cannabis in the past 12 months reported driving after cannabis use, a significant decline from 27% in 2018.”

Published

on

By


The 2024 Canadian Cannabis Survey provides important insights into Canadians’ knowledge, attitudes and behaviours on cannabis use

December 6, 2024 | Ottawa, Ontario | Health Canada

An important part of the Government of Canada’s public health approach to legalizing and strictly regulating cannabis is ongoing and comprehensive surveillance, data collection and evidence gathering. The results from the annual Canadian Cannabis Survey provide a snapshot of public health and public safety data on cannabis in Canada.

Today, Health Canda published the 2024 Canadian Cannabis Survey (CCS) results. The data was collected from April 4th to July 2nd, 2024.

Since 2017, Health Canada has conducted the annual Canadian Cannabis Survey to better understand attitudes and knowledge regarding cannabis, as well as patterns of cannabis use in Canada. Through the information gathered, Health Canada can better understand where support is needed the most and develop program initiatives that will help educate and raise awareness around the use of cannabis.

Findings from the 2024 survey include:

  • The proportion of people in Canada who report smoking cannabis continues to decline. That said, smoking remains the most common method of consuming cannabis (69%), followed by eating (57%) and vaporizing with a vape pen or e-cigarette (37%).
  • The number of respondents who reported getting cannabis from a legal source in 2024 was 72% – an increase from 37% in 2019 to 72% in 2024, with legal storefronts being the most common source since 2019. A smaller proportion reported accessing cannabis through illegal sources (3%) compared to 2019 (16%).
  • 18% of people who had used cannabis in the past 12 months reported driving after cannabis use, a significant decline from 27% in 2018.
  • There was no change in rates of cannabis use among youth (age 16-19) over the past year. Past 12-month cannabis use among youth aged 16-19 was 41%, similar to several previous years (44%, 44%, and 43% in 2019, 2020 and 2023 respectively).
  • Overall, the proportion of respondents who said they used cannabis and reported daily, or almost daily use has been stable since 2018 (approx. 25%), including among youth (approx. 20%).
  • The percentage of people in Canada who said they use cannabis who are ‘at high risk’ of developing problems from cannabis use has remained stable since 2018 (approx. 3%).

Health Canada has made significant investments to educate youth and young adults about the health risks of cannabis, as they are at an increased risk of experiencing adverse effects from cannabis use since the brain continues to develop up until around the age of 25. These efforts include the Spring 2022 Reduce your risk: Choose legal cannabis public education campaign, the Prevention of Accidental Paediatric Cannabis Poisonings among Children campaign in Spring 2023, and the Pursue Your Passion: A Teen Cannabis Education Program, which was re-launched in March 2023 as a virtual program to educate youth and young adults about the health effects of cannabis. The department has also produced public education material that emphasizes the importance of storing cannabis securely away from children and pets.



Source link

Continue Reading

breaking news

Marijuana Moment: GOP Leaders Blocked Schumer’s Push To Include Cannabis Banking Reform In Government Funding Bill, Senate Source Says

Published

on

By


MM write

Republican House and Senate leadership “openly and solely blocked” Senate Majority Leader Chuck Schumer’s (D-NY) attempt to include bipartisan marijuana banking legislation in a government funding bill, a Senate source familiar with the negotiations tells Marijuana Moment.

As bicameral lawmakers have worked to put together a continuing resolution to keep the government funded, Schumer repeatedly urged colleagues across the aisle to incorporate the Secure and Fair Enforcement Regulation (SAFER) Banking Act, to no avail. Senate Minority Leader Mitch McConnell (R-KY) and House Speaker Mike Johnson (R-LA) killed that prospective deal, the source said.

“Schumer pushed for SAFER Banking at the negotiation table in the CR multiple times. This week, both Speaker Johnson and Leader McConnell strongly rejected it,” they said. “For years some Republicans have done a dance telling marijuana businesses that they supported SAFER, while Republican leadership has openly and solely blocked it at every turn.”

GOP Leaders Blocked Schumer’s Push To Include Marijuana Banking Reform In Government Funding Bill, Senate Source Says



Source link

Continue Reading
Advertisement

Trending

Copyright © 2021 The Art of MaryJane Media